





(n¼19 lesions) p value
Qualitative Findings:
Subintimal GW tracking, n (%)* 33(21.1) 19 (100) <0.001
Dissection Flap, n (%) 64 (41.6) 16 (84.2) <0.001
Dissected segment location
Proximal, n (%) 27 (17.5) 9 (47.4)
Distal, n (%) 24 (15.6) 5 (26.3) 0.003
Body, n (%) 13 (8.4) 2 (10.5)
Coronary Hematoma, n (%) 17 (11) 6 (32) 0.01
Calciﬁcation (>30o arc), n (%) 141 (92) 16 (84) 0.29
Calciﬁcation morphology
Superﬁcial, n (%) 98 (64) 7 (37) 0.02
Deep, n (%) 43 (28) 9 (47) 0.08
Quantitative Findings:
Dissection length, mm 5.4 (4 to 9) 4.2 (3 to 8.5) 0.27
Maximum arc of calcium,o 274  132 150  106 0.68
Proximal reference EEM CSA, mm2 15.7  4.4 14.4  3.6 0.2
Proximal reference lumen CSA, mm2 9.7  2.9 8.2  2.3 0.03
Distal reference EEM CSA, mm2 8.2  3.3 7.2  2.2 0.08
Distal reference lumen CSA, mm2 5.3  2 5.1  2 0.74
Post-Stent IVUS measurements:
Mean stent CSA, mm2 6.9  1.9 6.7  2.3 0.71
Stent Expansion 0.87  0.32 0.92  0.30 0.55
Stent symmetry index 0.89  0.02 0.92  0.086 0.23
Values are mean  SD, median (interquartile range), or n (%).
CSA indicates cross-sectional area; EEM, external elastic membrane; IVUS, intravascular
ultrasound.* immediately after wiring or after pre-dilation with a 1 to 2.0-mm balloon.{ ﬁnal
guidewire position in a false lumen with subsequent stent deployment in subintimal space.
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associated with procedural success and procedural complications.
Results: During the study period, CTO PCI represented 3.8% of the total PCI volume
for stable coronary artery disease (22,365 of 594,510). Overall, patients undergoing
CTO PCI required higher contrast volume and ﬂuoroscopy time and had lower
procedural success (59% vs. 96%, P< 0.001) and higher MACE rate (1.6% vs. 0.8%,
P< 0.001) than non CTO patients. On multivariable analysis, several parameters
(including older age, current smoking, prior MI, prior CABG, prior peripheral arterial
disease, prior cardiac arrest, right coronary artery CTO target vessel, and less operator
experience), were associated with lower likelihood of CTO PCI procedural success,
while operators’ annual CTO PCI volume was associated with improved success
without signiﬁcant increase in major complications.
Conclusions: CTO PCI is currently performed infrequently in the US for stable
coronary artery disease and is associated with lower procedural success and higher
complication rates compared with non-CTO PCI. Procedural success was associated
with several patient factors and operator experience.
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Long-term follow up after antegrade versus retrograde recanalization of chronic
total coronary occlusions
Klaudija Bijuklic1, Carsten Schwencke1, Joachim Schofer1
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Background: The recanalization success rate of chronic total coronary occlusions
(CTO-PCI) can be increased by a retrograde approach. The impact of the retrograde
compared to the antegrade PCI on long-term outcome is unknown. Aim of the study
was to evaluate the long-term MACCE rate (death, myocardial infarction, coronary
bypass surgery and stroke) in patients after retrograde versus antegrade CTO-PCI.
Methods: In a prospective study from January 2008 to June 2012 436 consecutive
patients with CTO’s ( 3 months old) were enrolled.
Results:Mean age was 63.4  10.3 years, 86% were male. The retrograde PCI, which
was used only after a failed antegrade intervention, was performed in 18 % (n¼79) of
patients. Patients with retrograde CTO-PCI had more frequently previous bypass
surgery, RCA as target vessel (79.7% vs. 56%.8, p< 0.0004), longer lesion length (46
vs. 30 mm, p< 0.001), longer procedure duration (108.2 vs. 63.2 min, p< 0.0001),
higher contrast volume (433.6 vs. 267.6 ml, p< 0.0001), longer ﬂuoroscopy time
(61.2 vs 30.1 min, p< 0.0001) and higher radiation exposure (285.3 vs. 145,0
Gycm2m p< 0.0001). Long-term overall MACCE rate (mean follow up 590  461
days) was not different after retrograde vs. antegrade CTO-PCI (14.3% vs. 15.1 %).
Same was true for the components of MACCE (death 5.7 vs. 8.5%, myocardial
infarction 2.8 vs. 2.6%, bypass surgery 8.6 vs. 5.3%, stroke 0 vs. 2.6%). However,
patients with failed antegrade PCI had a signiﬁcantly higher long-term MACCE rate
compared to successful antegrade PCI (29.2 vs. 12.5%, p< 0.04), whereas the MACCE
rate of failed vs. successful retrograde PCI was not different (14.3 vs. 14.3%).
Conclusions: Despite more patients with previous coronary bypass surgery and more
complex target lesions and procedures the overall long-term MACCE rate after
retrograde CTO-PCI is not different to antegrade CTO-PCI. Why the long-term
MACCE rate is higher only after failed vs. successful antegrade but not after failed vs.
successful retrograde CTO-PCI deserves further studies.
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Background: We evaluated the in-hospital and the long-term clinical and angio-
graphic outcomes of drug-eluting stents (DES) deployed in true versus false lumen of
successfully crossed chronic total occlusions (CTO)
Methods: Between August 2011 and October 2012, 157 consecutive patients with
173 CTO lesions were successfully recanalized in a single center. All procedures were
guided with intravascular ultrasound (IVUS). After successful guidewire crossing,
lesions were classiﬁed according to IVUS evaluation into 2 groups; (1) true lumen
group and, (2) subintimal stenting group; and compared with regards to in-hospital
and long term clinical outcomes
Results: In 154 lesions, DES were deployed in the true lumen; and in 19 (11%) le-
sions, DES were deployed in the subintimal space (95% conﬁdence interval: 6.3% to
15.6%) with a success rate of 96 % and 82.4%, in antegrade and retrograde ap-
proaches, respectively. IVUS showed that the prevalence of dissection was two times
and intramural hematoma (IMH) was three times as higher in the subintimal stenting
group (p< 0.001 and p< 0.01, respectively).Subintimal stenting was associated with a
signiﬁcant increase in minor perforations 6/19 (31.6 % vs. 8.4%, p¼0.002), all were
managed conservatively. Kaplan-Meier analysis revealed a similar rates of binary
restenosis and target lesion revascularization between groups (p¼0.73 and p¼0.97,
respectively).Six patients (4.6%, 6 / 129 patients) in the true lumen group and none in
the subintimal group died at one yearJACC Vol 64/11/Suppl B j September 13–17, 2014 j TCT Abstracts/CoIVUS FindingsConclusions: Subintimal stent deployment in CTO segments, using second generation
DES with IVUS guidance, carries a similar success rate and long-term angiographic
and clinical outcomes as true lumen stenting
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Background: Transradial access is often used in percutaneous coronary inter-
vention(PCI) for chronic total occlusions (CTO), however, its efﬁcacy and safety in
this setting have received limited study.
Methods: We compared the technique and outcomes of transradial vs. transfemoral
access among 650 CTO PCI cases performed between January 2012 and March 2014
at 6 US centers.
Results: Most patients were men (87%) with high frequency of diabetes mellitus
(42%) and prior coronary artery bypass graft surgery (36%). The CTO target vessel
was the right coronary (59%), left anterior descending (20%), or circumﬂex (17%)
artery. TR access was used in 110 (17%) of the 650 cases, as follows: bilateral radial
access (63%); bilateral radial access plus unilateral or bilateral femoral access (7%);
unilateral radial access plus unilateral or bilateral femoral access (26%); and unilateral
radial access (4%). Six and eight French guide catheters were used through the radial
and femoral artery, respectively. Compared to transfemoral, transradial cases had
similar technical (92.6% vs. 93.0%, p¼0.87) and procedural (91.1% vs. 90.0%,
p¼0.95) success and major complication rates (1.7% vs 1.8 %, p¼0.99). However,
transradial access was associated with higher mean procedure (14283 vs. 12060
min, p¼0.008) and ﬂuoroscopy (5840 vs. 4931 min, p< 0.026) time, and number
of crossing approach changes (0.71.0 vs. 0.50.7, p¼0.008).ronary Lesions - CTO B57
